Product Overview 5-amino-1mq 126mg research peptide is supplied exclusively for laboratory and analytical research
Important Safety Information Do not use AOD-9604 if you: Have active cancer or malignancy (use only under medical supervision with appropriate monitoring) Are pregnant or breastfeeding (safety data lacking in these populations) Have known allergy to growth hormone fragments or peptide compounds Have severe uncontrolled metabolic or cardiovascular disease without medical supervision Common side effects may include: Injection site reactions (mild redness, swelling, or tenderness), occasional mild headaches during initial use, and transient lightheadedness
Research resources Guidance from the Solix bench Practical notes on documentation, handling and quality, written for research buyers
Evidence Ledger: What the Research Actually Shows Plain statement: No phase II or III human RCT for BPC-157 in any indication has been published as of May 2026
continued improvement for chronic Weeks 8-12: Maximum benefit achieved
TB-500 Guide GHK-Cu Guide Guide FAQ Quick answers about guide scope, access, and educational use context